Monitoring of inflammation in remodelling

E-poster session
Chairs: S. Loukides (Athens, Greece), A. Spanevello (Milan, Italy)

Late Breaking Abstract - Biological determinants of sputum rheology in chronic airway diseases M. Volpato (Montpellier, France), J. Vialaret (Montpellier, France), C. Hirtz (Montpellier, France), C. Suehs (Montpellier, France), E. Matzner-Lober (Montpellier, France), I. Vachier (Montpellier, France), N. Molinari (Montpellier, France), A. Bourdin (Montpellier, France), J. Charriot (Montpellier, France)
Exogenous HSP60 stimulates airway smooth muscle cell remodeling via MAPK p38 pathway J. Li (Basel, Switzerland), L. Fang (Basel, Switzerland), D. Stolz (Basel, Switzerland), M. Tamm (Basel, Switzerland), M. Roth (Basel, Switzerland)
Adipokine mediators in asthma and COPD are affected by sex and age L. Andersson (Stockholm, Sweden), A. James (Stockholm, Sweden), S. Dahlén (Stockholm, Sweden), A. Bossios (Stockholm, Sweden), O. The Bioair Consortium (Stockholm, Sweden)
Correlation of serum Matrix metalloproteinase-9 and clinico-functional parameters in COPD patients S. Dimic Janjic (Beograd, Republic of Serbia), B. Milenkovic (Beograd, Republic of Serbia), M. Stjepanovic (Beograd, Republic of Serbia), J. Jankovic (Beograd, Republic of Serbia), J. Cvejic (Beograd, Republic of Serbia), I. Milivojevic (Beograd, Republic of Serbia)
Endothelial injury in COPD assessed by microalbuminuria (MAB) and von Willebrand factor levels (vWf:Ag) and activity (vWf:Ac) C. Chronis (Ioannina, Greece), C. Kyriakopoulos (Ioannina, Greece), E. Papapetrou (Ioannina, Greece), C. Tsaousi (Ioannina, Greece), A. Tatsioni (Ioannina, Greece), A. Gogali (Ioannina, Greece), C. Katsanos (Ioannina, Greece), K. Vaggeli (Ioannina, Greece), V. Bellou (Ioannina, Greece), M. Kosta (Ioannina, Greece), A. Spanou (Ioannina, Greece), C. Tselepi (Ioannina, Greece), A. Charisis (Ioannina, Greece), G. Daskalopoulos (Ioannina, Greece), S. Constantopoulos (Ioannina, Greece), K. Kostikas (Ioannina, Greece), A. Konstantinidis (Ioannina, Greece)
Establishing normal ranges for induced sputum cell counts in Singapore Y. Ng (Singapore, Singapore), T. Tay (Singapore, Singapore), M. Koh (Singapore, Singapore), X. Choo (Singapore, Singapore), A. Yii (Singapore, Singapore)
How different operators performing sputum eosinophil differential cell counts may affect clinical decisions for severe asthma patients. G. Tavernier (Manchester (Greater Manchester), United Kingdom), P. Aspin (Manchester (Greater Manchester), United Kingdom), S. Fowler (Manchester (Greater Manchester), United Kingdom), D. Allen (Manchester (Greater Manchester), United Kingdom), R. Niven (Manchester (Greater Manchester), United Kingdom)
Comparison of demographic, functional and inflammatory features between atopic and non atopic asthmatics. Retrospective study on a large cohort of patients. S. Gerday (Liège, Belgium), F. Schleich (Liège, Belgium), M. Henket (Liège, Belgium), V. Paulus (Liège, Belgium), F. Guissard (Liège, Belgium), R. Louis (Liège, Belgium)
Streptococcus pneumoniae augments inflammatory process in asthma model without changing Th2 profile R. M. Laia (São Paulo, Brazil), T. B.P Castro (São Paulo, Brazil), C. A. Santos (São Paulo, Brazil), B. M. Saraiva-Romanholo (São Paulo, Brazil), M. S. Oliveira (São Paulo, Brazil), E. N. Miyagi (São Paulo, Brazil), I. F.C.L. Tiberio (São Paulo, Brazil), C. Rosa Olivo (São Paulo, Brazil)
Correlation between Blood Eosinophilia and Fractional Exhaled Nitric Oxide in the diagnosis of Asthma within Primary Care. S. Ghosh (Leicester (Leicestershire), United Kingdom), L. Farrell (Leicester (Leicestershire), United Kingdom), G. Panray (Leicester (Leicestershire), United Kingdom)
The association between airway and systemic eosinophilia and symptoms and exacerbations differ between asthma and COPD patients D. Klein (Copenhagen, Denmark), T. Lapperre (Copenhagen, Denmark), U. Bødtger (Næstved, Denmark), K. Romberg (Höllviken, Sweden), L. Bjermer (Lund, Sweden), J. Erjefält (Lund, Sweden), K. Kristiansen (Copenhagen, Denmark), C. Porsbjerg (Copenhagen, Denmark)
Lower muscle mass is related to poorer clinical outcomes in moderate to severe asthma E. Visser (Leeuwarden, Netherlands), A. Azad (Leeuwarden, Netherlands), T. Van Zutphen (Leeuwarden, Netherlands), H. Kerstjens (Groningen, Netherlands), A. Ten Brinke (Leeuwarden, Netherlands), K. De Jong (Leeuwarden, Netherlands)
Distribution of T2 markers in real-life patients with asthma, COPD and asthma+COPD from the BREATHE study D. Klein (Copenhagen, Denmark), T. Lapperre (Copenhagen, Denmark), L. Frøssing (Copenhagen, Denmark), A. Silberbrandt (Copenhagen, Denmark), U. Bødtger (Næstved, Denmark), K. Romberg (Höllviken, Sweden), L. Bjermer (Lund, Sweden), J. Erjefält (Lund, Sweden), K. Kristiansen (Copenhagen, Denmark), C. Porsbjerg (Copenhagen, Denmark)
Relationship between clinical and radiological signs of bronchiectasis in COPD patients: Results from COSYCONET K. Kahnert (München, Germany), R. Jörres (München, Germany), H. Kauczor (Heidelberg, Germany), B. Jobst (Heidelberg, Germany), J. Biederer (Heidelberg, Germany), F. Biertz (Hannover, Germany), P. Alter (Marburg, Germany), J. Behr (Munich, Germany), P. Mertsch (Hannover, Germany), F. Trudzinski (Heidelberg, Germany), R. Bals (Homburg, Germany), T. Lucke (Munich, Germany), H. Watz (Grosshansdorf, Germany), C. Vogelmeier (Marburg, Germany), T. Welte (Hannover, Germany)
Genotyping and phenotyping of alpha1-antitrypsin deficiency Greek patients under augmentation therapy: a multicenter study S. Papiris (Athens, Greece), V. Apollonatou (Athens, Greece), A. Tzouvelekis (Athens, Greece), V. Tzilas (Athens, Greece), T. Karampitsakos (Athens, Greece), I. Gerogianni (Larissa, Greece), Z. Daniil (Larissa, Greece), L. Kolilekas (Athens, Greece), A. Tsaroucha (Athens, Greece), A. Papaioannou (Athens, Greece), S. Tryfon (Thessaloniki, Greece), S. Markou (Xanthi, Greece), I. Korbila (Athens , Greece), K. Vlami (Athens , Greece), A. Dimakou (Athens , Greece), I. Papanikolaou (Corfu, Greece), M. Kitrou (Patras, Greece), Z. Sardelis (Athens , Greece), E. Stagaki (Athens , Greece), G. Apollonatos (Athens , Greece), G. Verykokou (Athens , Greece), M. Kallieri (Athens , Greece), A. Prapa (Athens , Greece), Z. Tsilogianni (Athens , Greece), N. Roussakis (Athens , Greece), E. Antonogiannaki (Athens , Greece), G. Papadaki (Athens , Greece), G. Tsinti (Larissa, Greece), M. Speletas (Larissa, Greece), T. Greulich (Marburg, Germany), D. Bouros (Athens , Greece), E. Manali (Athens, Greece)
Polymorphisms for epoxide hydrolase, glutathione transferase and genetic susceptibility to COPD A. Tumurbaatar (Ulaanbaatar, Mongolia), I. Dashtseren (Ulaanbaatar, Mongolia), S. Jav (Ulaanbaatar, Mongolia), C. Ganbold (Ulaanbaatar, Mongolia)
Acute exacerbations of chronic obstructive pulmonary disease: current recommendations review and quality of evidence analysis. S. Tejada (Barcelona, Spain), J. Ferreira-Coimbra (Porto, Portugal), M. Gallego (Barcelona, Spain), C. Solé-Lleonart (Barcelona, Spain), A. Anzueto (Texas, United States of America), J. Rello (Barcelona, Spain)